Altshuler Shaham LTD Corcept Therapeutics Inc Transaction History

Altshuler Shaham LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$21.97 - $33.8 $15,994 - $24,606	728 New	728 $19,000
Q1 2023 May 09, 2023	SELL	$19.2 - $24.47 $49,536 - $63,132	-2,580 Closed	0 $0
Q4 2022 May 09, 2023	BUY	$19.95 - $29.96 $5,865 - $8,808	294 Added 12.86%	2,580 $52,000
Q3 2022 Nov 14, 2022	BUY	$24.7 - $29.12 $22,773 - $26,848	922 Added 67.6%	2,286 $58,000
Q2 2022 Aug 10, 2022	SELL	$17.33 - $25.3 $3,916 - $5,717	-226 Reduced 14.21%	1,364 $32,000
Q1 2022 May 16, 2022	BUY	$16.53 - $25.21 $26,282 - $40,083	1,590 New	1,590 $36,000
Q3 2020 Nov 10, 2020	SELL	$12.46 - $19.98 $16,845 - $27,012	-1,352 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$11.0 - $18.26 $14,872 - $24,687	1,352 New	1,352 $23,000

355

86.2M

1.12M

667K

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $7.17B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

Get notified when there are updates to the investment portfolio of Altshuler Shaham LTD, based on Form 13F filings with the SEC.

Stay updated on Altshuler Shaham LTD with notifications on news.